| Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy (NCT07220785) | Regeneron Pharmaceuticals | 2026-03-13 |
| A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease (NCT07419828) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-13 |
| A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma (NCT07456033) | GlaxoSmithKline | 2026-03-13 |
| FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors (NCT07181135) | University Medical Center Groningen | 2026-03-13 |
| Long-Term Open-Label Extension Study of Oral Levosimendan (NCT07436689) | Tenax Therapeutics, Inc. | 2026-03-13 |
| TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients (NCT06474273) | University of Sydney | 2026-03-13 |
| A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation (NCT07412470) | Sanofi | 2026-03-13 |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) (NCT07221149) | Bristol-Myers Squibb | 2026-03-13 |
| Safety of KN057 Prophylaxis in Patients With Haemophilia A or B (NCT07545395) | Suzhou Alphamab Co., Ltd. | 2026-03-13 |
| An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (NCT07424144) | Sanofi | 2026-03-12 |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) (NCT07361510) | Bristol-Myers Squibb | 2026-03-12 |
| Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) (NCT07457918) | Verrica Pharmaceuticals Inc. | 2026-03-11 |
| Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis (NCT07286058) | Takeda | 2026-03-11 |
| Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis (NCT07339111) | Medipost, Inc. | 2026-03-11 |
| A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children (NCT07402512) | Simcere Pharmaceutical Co., Ltd | 2026-03-11 |
| Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II. (NCT06822478) | Universidad de Antioquia | 2026-03-11 |
| SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ (NCT07442565) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026-03-10 |
| A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (NCT07332481) | EMD Serono Research & Development Institute, Inc. | 2026-03-10 |
| Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML (NCT07486479) | The First Affiliated Hospital of Soochow University | 2026-03-10 |
| Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients (NCT07630779) | Beni-Suef University | 2026-03-10 |
| Functional Restoration for Chronic Low Back Pain: Medico-economic Impact (NCT07472374) | Assistance Publique - Hôpitaux de Paris | 2026-03-10 |
| A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma (NCT07452198) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2026-03-09 |
| Multiprofen-CC to Reduce Pain in Hand Arthritis (NCT06966206) | St. Joseph's Healthcare Hamilton | 2026-03-09 |
| Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma (NCT07491445) | Revolution Medicines, Inc. | 2026-03-09 |
| Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. (NCT07402213) | Jemincare | 2026-03-09 |
| REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis (NCT07410117) | Regeneron Pharmaceuticals | 2026-03-09 |
| A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) (NCT07349329) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2026-03-09 |
| Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) (NCT07277582) | Thryv Therapeutics, Inc. | 2026-03-07 |
| A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer (NCT07441460) | Shanghai JMT-Bio Inc. | 2026-03-06 |
| Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) (NCT06907173) | University of Virginia | 2026-03-06 |
| Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer (NCT07500701) | Samsung Medical Center | 2026-03-06 |
| A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus (NCT07438496) | Janssen Research & Development, LLC | 2026-03-05 |
| QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia (NCT07444086) | Qilu Pharmaceutical Co., Ltd. | 2026-03-05 |
| Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC (NCT07459296) | First Affiliated Hospital of Guangxi Medical University | 2026-03-05 |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer (NCT07284849) | Incyte Corporation | 2026-03-05 |
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer (NCT07349069) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-04 |
| A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) (NCT07500207) | Changchun BCHT Biotechnology Co. | 2026-03-04 |
| Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma (NCT07445048) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-03-04 |
| Safety and Potency of a High Cabergoline Dosage in Microprolactinomas (NCT07463235) | University of Sao Paulo General Hospital | 2026-03-04 |
| Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine (NCT07416110) | Sinovac Biotech Co., Ltd | 2026-03-04 |
| A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis (NCT07432854) | Dermavon Holdings Limited | 2026-03-03 |
| Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion (NCT07442136) | Colgate Palmolive | 2026-03-03 |
| A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection. (NCT07658534) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2026-03-03 |
| LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 (NCT07288398) | Tenax Therapeutics, Inc. | 2026-03-03 |
| Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone (NCT07257198) | Montreal Heart Institute | 2026-03-03 |
| Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer (NCT07472868) | J. W. A. Burger | 2026-03-03 |
| Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration (NCT07269808) | Massachusetts General Hospital | 2026-03-03 |
| Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer (NCT07436741) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-03 |
| Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) (NCT06891950) | Butantan Institute | 2026-03-03 |
| A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy (NCT07434050) | Hangzhou Sciwind Biosciences Co., Ltd. | 2026-03-02 |
| Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment (NCT07160686) | University of Birmingham | 2026-03-02 |
| Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (NCT07464587) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-03-01 |
| Neuroprotection of Memantine and Rosuvastatin (NCT07504198) | Tanta University | 2026-03-01 |
| A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma (NCT07392866) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2026-03-01 |
| Synergistic Minimally Invasive Surgery and Deferoxamine in ICH (NCT07162363) | University of Illinois at Chicago | 2026-03-01 |
| Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (NCT06975111) | University of Colorado, Denver | 2026-03-01 |
| A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs (NCT07483684) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-03-01 |
| Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR) (NCT06695962) | University Hospital, Rouen | 2026-03-01 |
| Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) (NCT07223814) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2026-03-01 |
| The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy (NCT07475065) | Universitas Sebelas Maret | 2026-03-01 |
| Better Options for Lymphatic Filariasis Treatment (NCT07159373) | Medicines Development for Global Health | 2026-03-01 |
| Albumin in Acute Variceal Bleeding (NCT07395141) | King George's Medical University | 2026-03-01 |
| A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants (NCT07439510) | Spinogenix | 2026-03-01 |
| Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial (NCT07396480) | First Affiliated Hospital of Zhejiang University | 2026-03-01 |
| Intracervical Balloon Placement With Nitrous Oxide Administration (NCT06498908) | Olivia Sher | 2026-03-01 |
| Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window (NCT07476898) | First Hospital of China Medical University | 2026-03-01 |
| A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration (NCT07489586) | Qilu Pharmaceutical Co., Ltd. | 2026-03-01 |
| A Phase 3 Trial of JKN2401 Injection in COPD (NCT07330310) | Joincare Pharmaceutical Group Industry Co., Ltd | 2026-03-01 |
| Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. (NCT07483736) | Versailles Hospital | 2026-03-01 |
| A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer (NCT07318883) | Shanghai Henlius Biotech | 2026-03-01 |
| A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) (NCT07313774) | Cinclus Pharma Holding AB | 2026-03-01 |
| Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women (NCT07395895) | Badr University | 2026-03-01 |
| Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (NCT07414706) | Centre Hospitalier Universitaire, Amiens | 2026-03-01 |
| 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial (NCT07346235) | American Hospital 2 Kosovo | 2026-03-01 |
| Tranexamic Acid vs Vasopressin in Placenta Previa Trial (NCT07423156) | Allama Iqbal Medical College | 2026-03-01 |
| Comparison Between Total Intravenous Anesthesia With Magnesium Sulphate Versus Total Intravenous Anesthesia With Dexmedetomidine in Patients Undergoing Lumbar Spine Surgeries (NCT07443163) | Cairo University | 2026-03-01 |
| Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) (NCT07427043) | Brigham and Women's Hospital | 2026-03-01 |
| Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial (NCT07445191) | Cairo University | 2026-03-01 |
| Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth (NCT07393802) | University of Baghdad | 2026-03-01 |
| 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors (NCT07463313) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2026-03-01 |
| Efavirenz for the Treatment of Creutzfeldt-Jakob Disease (NCT07482085) | Xuanwu Hospital, Beijing | 2026-03-01 |
| Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil (NCT05637710) | Eurofarma Laboratorios S.A. | 2026-03-01 |
| Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis (NCT07347626) | Xinqiao Hospital of Chongqing | 2026-03-01 |
| Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer (NCT07286162) | University Health Network, Toronto | 2026-03-01 |
| Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy (NCT07651176) | First Affiliated Hospital of Zhejiang University | 2026-03-01 |
| Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AI (NCT07376304) | Hospital del Rio Hortega | 2026-03-01 |
| Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis (NCT07353671) | West China Hospital | 2026-03-01 |
| Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement (NCT07373262) | University Hospital, Toulouse | 2026-03-01 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen (NCT07055295) | Sinovac Biotech Co., Ltd | 2026-03-01 |
| Bacterial Reduction for a Manual Toothbrush With a 360-Degree Mouth Cleaner Design Versus a Standard Toothbrush (NCT07471477) | Colgate Palmolive | 2026-03-01 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen (NCT07055893) | Sinovac Biotech Co., Ltd | 2026-03-01 |
| Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest (NCT03176186) | Invero Pharma, Inc. | 2026-03-01 |
| Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma (NCT07385079) | Sun Yat-sen University | 2026-03-01 |
| Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy (NCT07651163) | First Affiliated Hospital of Zhejiang University | 2026-03-01 |
| Efficacy and Safety of Tazbentetol in ALS Participants (NCT07325591) | Spinogenix | 2026-03-01 |
| Evaluating Suzetrigine for Pain Control Following TKA (NCT07357376) | AdventHealth | 2026-03-01 |
| Acute Sodium Bicarbonate Supplementation in Female Basketball Players (NCT07730606) | Krzysztof Durkalec-Michalski | 2026-03-01 |
| A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia (NCT07255872) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-03-01 |
| Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris (NCT06905210) | Eurofarma Laboratorios S.A. | 2026-03-01 |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy (NCT07461441) | Yeungnam University College of Medicine | 2026-03-01 |